CVSG.F Stock Overview
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 1/6 |
Past Performance | 4/6 |
Financial Health | 4/6 |
Dividends | 3/6 |
CVS Group plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£19.94 |
52 Week High | UK£19.94 |
52 Week Low | UK£18.99 |
Beta | 0.95 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | 160.65% |
Change since IPO | 45.02% |
Recent News & Updates
Recent updates
Shareholder Returns
CVSG.F | US Healthcare | US Market | |
---|---|---|---|
7D | 0% | -1.3% | -3.5% |
1Y | n/a | -2.9% | 20.2% |
Return vs Industry: Insufficient data to determine how CVSG.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how CVSG.F performed against the US Market.
Price Volatility
CVSG.F volatility | |
---|---|
CVSG.F Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 7.2% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.5% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CVSG.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CVSG.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 9,100 | Richard William Fairman | www.cvsukltd.co.uk |
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.
CVS Group plc Fundamentals Summary
CVSG.F fundamental statistics | |
---|---|
Market cap | US$839.76m |
Earnings (TTM) | US$44.00m |
Revenue (TTM) | US$797.86m |
19.1x
P/E Ratio1.1x
P/S RatioIs CVSG.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CVSG.F income statement (TTM) | |
---|---|
Revenue | UK£641.90m |
Cost of Revenue | UK£365.20m |
Gross Profit | UK£276.70m |
Other Expenses | UK£241.30m |
Earnings | UK£35.40m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Sep 26, 2024
Earnings per share (EPS) | 0.49 |
Gross Margin | 43.11% |
Net Profit Margin | 5.51% |
Debt/Equity Ratio | 59.6% |
How did CVSG.F perform over the long term?
See historical performance and comparison